The NIH, FDA and Bill and Melinda Gates Foundation are working with a San Francisco startup whose calling card is an AI-enabled engine that renders patient data unidentifiable by reproducing it in synthetic versions.

Last Tuesday the FDA posted an action plan telling how it will evaluate AI for medical applications going forward. Three days later the agency officially proposed letting numerous products through without review. 

If the hospitals of America’s most populous city are any sort of bellwether, CMS is going to have its hands full trying to enforce compliance with the Trump Administration’s executive order on price transparency.

After perusing info on AI startups as compiled by Crunchbase, Forbes senior contributor Louis Columbus has named one “to watch” in 2021 that serves exclusively healthcare.

The FDA’s new Digital Health Center of Excellence has released a document describing how it will henceforth oversee and evaluate software that incorporates AI and machine learning for medical applications.

AI researchers and developers across the U.S. received a powerful if overshadowed shot in the arm on New Year’s Day.

Of 52 AI models analyzed by MIT’s Center for Information Systems Research over the past two years, 31 have been deployed. The rest were in pilot phases or under development.

UnitedHealth Group is acquiring Change Healthcare for about $8 billion cash, the companies jointly announced Wednesday morning.